Using Alternating Tangential Flow in a 3000-L perfusion bioreactor, the company expects to reduce production time by up to 30% At its manufacturing site in Songdo, South Korea, Samsung BioLogics (SBL) ...

Repligen acquired Refine Technology and its Alternating Tangential Flow system for continuous bioprocessing. Repligen acquired the business of Refine Technology, including Refine's Alternating ...

Upstream’s Relatively Continuous Flows Raise Hopes for Continuous Purification Perfusion culture has been employed for at least 20 years in bioprocessing, but it is now catching on as the upstream ...

Upstream process intensification using perfusion cell culture has become a necessity for meeting today’s demand in monoclonal antibodies (mAbs) bioprocessing. By sustaining higher viable cell ...

Samsung BioLogics has implemented new perfusion technology that would reduce production time by up to 30 percent for its clients, the contract drug manufacturer said Monday. The company said it has ...

New York, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Tangential Flow Filtration Market - Global Industry Size, Share ...

Repligen Corporation has announced that it has completed an 11,000 square foot expansion of its U.S. manufacturing facility. The expansion includes a dedicated space for the production and assembly of ...